Product Images Alendronate Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Alendronate Sodium NDC 50090-5474 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - alendronate fig1
Figure 2 - alendronate fig2
Figure 3 - alendronate fig3
This appears to be a chart showing the mean percent change from baseline in lumbar spine bone mineral density (BMD) in postmenopausal women treated with alendronate 10 mg/day versus placebo over a period of 36 months. The study is a multinational study, and the chart shows the effect of the treatment over time, with months plotted along the x-axis and the percent change in BMD plotted along the y-axis.*
Figure 4 - alendronate fig4
Studies in Glucocorticoid - Treated Patients Increase in BMD Alendronate 5 mg/day at One Year - alendronate fig5
Studies in Paget's Disease of Bone Effect on Serum Alkaline Phosphatase of Alendronate 40 mg/day Versus placebo or Etidronate 400 mg/day - alendronate fig6
The text provides information on the effect of Alendronate 40mg/day on serum alkaline phosphatase in Paget’s disease of bone compared to Placebo or Etidronate 400mg/day through a multinational and US study conducted over a period of 6 months. It also shows a mean % change from Baseline.*
Chemical Structure - alendronate str
Label Image - lbl500905474
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.